PATEL DHAVALKUMAR DHIRAJLAL (EVP, Chief Scientific Officer) exercised options at SANA BIOTECHNOLOGY, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 8/27/2026ACC: 0002115339-26-000004
Officer· EVP, Chief Scientific Officer
Since Mar 2026
-41.16K
Net shares
Net seller
$169.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
125K acquired · 166.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+125K
Price / share
—
Trade value
—
% of position
125.6%
8/26/2026
99.51K→224.51K
Common Stock
Direct
Shares
−41.16K
Price / share
$4.11
Trade value
$169.16K
% of position
18.3%
8/27/2026
224.51K→183.35K
Total
Net shares
+83.84K
Net value
-$169.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2026 | M · Option Exercise | +125K | — | — | 125.6% | 99.51K | 224.51K |
| Common Stock Direct | 8/27/2026 | F · Tax Withholding | −41.16K | $4.11 | $169.16K | 18.3% | 224.51K | 183.35K |
| Total | +83.84K | -$169.16K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
125K shares
Shares
−125K
Strike price
Held after
250K
Exercisable
—
8/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock125K shares | 8/26/2026 | M · Option Exercise | −125K | — | 250K |